CAPS Medical was selected among the first innovators to present at LSI Europe 2023 at Barcelona

CAPS Medical CEO and Co-Founder Ilan Uchitel has presented the latest company's news and progress at LSI23 - Life Science Intelligence™'s Emerging MedTech Summit

CAPS Medical is excited to welcome Prof. Boris Chertin to the Scientific Advisory board, where he will be working with us on expanding the clinical reach of our selective minimally invasive NTAP™ technology, aiming to change the way solid tumors are treated in the future.

CAPS Medical has presented at LSI Europe 22 - Life Science Intelligence™'s Emerging MedTech Summit

CAPS Medical Enrolls Patients from Sheba Medical Center in First Ever Study for Treatment of Bladder Cancer Using Selective Endoscopic Cancer Treatment Technology

CAPS Medical is gearing up for clinical trials of its breakthrough system that delivers non-thermal atmospheric plasma (NTAP™) to treat-tumors.

CAPS Medical receives Notice of Allowance for it’s first Global family of patents. The allowed applications cover CAPS Medical’s Non Thermal Plasma NTAP™ technology In US, Europe Asia and Israel.

Our CEO Ilan Uchitel took part in International Workshop on Plasma for Cancer Treatment (IWPCT-2021).

CAPS Medical is Revolutionizing Cancer Treatment

CAPS Medical Closes Funding Round to Conduct Clinical Study to Treat Cancer

Congratulations to our Executive Chairman, Harel Gadot, for being chosen as one of the TOP 25 VOICES IN HEALTHCARE ROBOTICS!

We are excited to welcome Boris Kogan as our new VP of Research and Development

We are excited to welcome Prof. S. Nahum Goldberg to the Scientific Advisory Board

CAPS Medical was featured in Season 4 of True Future: Israel.

Israeli Startup Aims to Treat Tumors Without a Surgery (Hebrew)

Caps Medical Closes $3.5M Series A Funding

Israeli startup scores $3.5M bringing non-invasive cancer solution to the table

CAPS Medical Completes $3.5 Million Series A Round for Selective Cancer Treatment Technology

We were excited to have Jacob Cohen MD. present CAPS Medical technology and it's advantage in selectively treating solid tumors at the Annual Meeting of The Israeli Society of Otolaryngology Head and Neck Surgery.

We were pleased to have CAPS Medical CEO Ilan Uchitel present our technology last week at a Rambam Medtech event highlighting young companies making an impact.

Israeli start-up creates new tech to target internal solid tumors